We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 23

Federal Circuit split panel Opinion limits joint infringement to single entity
  • King & Spalding LLP
  • USA
  • May 29 2015

In a Federal Circuit split panel Opinion on May 13, 2015 in Akamai v. Limelight, Appeal Nos. 2009-1372, 1380, 1416 and 1417, the Majority held the


Appellee Commission and intervenor cross match submit briefs supporting overturning Federal Circuit split panel decision in Suprema
  • King & Spalding LLP
  • USA
  • October 30 2014

On October 15, 2014, Appellee Commission filed an En Banc Brief and Intervenor Cross Match filed a Brief on Rehearing En Banc urging the full Federal


Supreme Court may decide issue of the level of specificity required under Rule 9(b) in FCA whistleblower suits
  • King & Spalding LLP
  • USA
  • October 14 2013

The United States Supreme Court recently indicated its potential interest in hearing arguments in a key False Claims Act (FCA) case that would


D.C. Circuit’s invalidation of President Obama’s recess appointments raises questions concerning actions taken by the Consumer Financial Protection Board’s director
  • King & Spalding LLP
  • USA
  • February 7 2013

On January 25, 2013, the U.S. Court of Appeals for the D.C. Circuit held that President Obama’s recess appointments to the National Labor Relations


Two petitions for certiorari urge the Supreme Court to clarify the standard for proving falsity under the FCA
  • King & Spalding LLP
  • USA
  • October 3 2011

In parallel cases arising from the First Circuit, two healthcare corporations, Blackstone Medical, Inc. and Amgen, Inc., have petitioned the United States Supreme Court for certiorari to clarify the parameters of when a claim for payment can be deemed “legally false” under the federal False Claims Act.


U.S. Supreme Court rules Vermont prescription data privacy law unconstitutional
  • King & Spalding LLP
  • USA
  • June 24 2011

The United States Supreme Court issued its decision in Sorrell v. IMS Health, Inc., et al. on June 23, 2011.


Peter Todaro
  • King & Spalding LLP

Caitlyn Ozier
  • King & Spalding LLP

Tony V Pezzano
  • King & Spalding LLP